Daxor Net Profit Margin 2010-2011 | DXR
Daxor net profit margin from 2010 to 2011. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Daxor Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2011-12-31 | $0.00B | $-0.01B | inf% |
| 2011-09-30 | $0.00B | $-0.00B | inf% |
| 2011-06-30 | $0.00B | $0.00B | inf% |
| 2011-03-31 | $0.00B | $0.00B | inf% |
| 2010-12-31 | $0.00B | $0.01B | inf% |
| 2010-09-30 | $0.00B | $0.00B | inf% |
| 2010-06-30 | $0.00B | $0.00B | inf% |
| 2010-03-31 | $0.00B | $0.01B | inf% |
| 2009-12-31 | $0.00B | $0.01B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.046B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $17.425B | 10.54 |
| Quest Diagnostics (DGX) | United States | $15.213B | 15.72 |
| DaVita (DVA) | United States | $12.075B | 15.00 |
| Chemed (CHE) | United States | $8.786B | 27.23 |
| Encompass Health (EHC) | United States | $8.647B | 22.13 |
| Elanco Animal Health (ELAN) | United States | $6.680B | 15.19 |
| Option Care Health (OPCH) | United States | $5.270B | 19.95 |
| RadNet (RDNT) | United States | $3.877B | 104.94 |
| Amedisys (AMED) | United States | $3.018B | 21.38 |
| LifeStance Health (LFST) | United States | $2.668B | 0.00 |
| Astrana Health (ASTH) | United States | $2.125B | 28.74 |
| Addus HomeCare (ADUS) | United States | $1.712B | 24.49 |
| U.S Physical Therapy (USPH) | United States | $1.591B | 42.58 |
| Pennant (PNTG) | United States | $0.628B | 33.19 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.454B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.343B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.025B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.020B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.013B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.005B | 0.00 |